Journal article
The PASCAL Device-Early Experience with a Leaflet Approximation Device: What Are the Benefits/Limitations Compared with the MitraClip?
- Corpataux N Department of Cardiology, Bern University Hospital, University of Bern, 3010, Bern, Switzerland.
- Winkel MG Department of Cardiology, Bern University Hospital, University of Bern, 3010, Bern, Switzerland.
- Kassar M Department of Cardiology, Bern University Hospital, University of Bern, 3010, Bern, Switzerland.
- Brugger N Department of Cardiology, Bern University Hospital, University of Bern, 3010, Bern, Switzerland.
- Windecker S Department of Cardiology, Bern University Hospital, University of Bern, 3010, Bern, Switzerland.
- Praz F Department of Cardiology, Bern University Hospital, University of Bern, 3010, Bern, Switzerland. fabien.praz@insel.ch.
- 2020-06-29
Published in:
- Current cardiology reports. - 2020
Edge-to-edge valve repair
Leaflet approximation
MitraClip
Mitral regurgitation
PASCAL
Transcatheter mitral valve repair
Transcatheter tricuspid valve repair
Tricuspid regurgitation
English
PURPOSE OF REVIEW
This review article describes the technical features of the novel Edwards PASCAL transcatheter valve repair system as well as the evidence accumulated so far.
RECENT FINDINGS
Transcatheter mitral and tricuspid valve leaflet approximation enable treatment of patients with mitral and tricuspid regurgitation who are not eligible for surgery. The PASCAL device offers an alternative that may allow to overcome some of the limitations of previous systems and open the path for an approach adapted to individual patient's anatomy. Early data show similar safety and efficacy compared with the Abbott MitraClip system. The PASCAL system is a valuable addition to the armamentarium of transcatheter mitral and tricuspid valve repair devices. Randomized head-to-head comparisons and long-term data are needed to confirm the promising results observed so far.
This review article describes the technical features of the novel Edwards PASCAL transcatheter valve repair system as well as the evidence accumulated so far.
RECENT FINDINGS
Transcatheter mitral and tricuspid valve leaflet approximation enable treatment of patients with mitral and tricuspid regurgitation who are not eligible for surgery. The PASCAL device offers an alternative that may allow to overcome some of the limitations of previous systems and open the path for an approach adapted to individual patient's anatomy. Early data show similar safety and efficacy compared with the Abbott MitraClip system. The PASCAL system is a valuable addition to the armamentarium of transcatheter mitral and tricuspid valve repair devices. Randomized head-to-head comparisons and long-term data are needed to confirm the promising results observed so far.
- Language
-
- English
- Open access status
- closed
- Identifiers
-
- DOI 10.1007/s11886-020-01305-1
- PMID 32594261
- Persistent URL
- https://folia.unifr.ch/global/documents/157362
Statistics
Document views: 14
File downloads: